News
What's happening at Unlimited Bio
Trial announcements, conferences, partnerships, and press coverage — 25 updates so far.
Unlimited Bio Wins the Vitalist Bay Pitch Competition
Unlimited Bio took first place at the Vitalist Bay pitch competition, ahead of Frontier Bio and Sundial Therapeutics, in a lineup of frontier longevity and biotech startups.
Read more
VEGF now available on Bahamas
Unlimited Bio's VEGF gene therapy is now offered at GARM Bahamas Ltd., the newly opened flagship clinic at Hurricane Hole Marina on Paradise Island. Building on a 12-year legacy in regenerative medicine, GARM delivers world-class longevity care led by a d
Read more
Unlimited Bio CALM-AF-AI Trial Announcement
Unlimited Bio opens recruitment for CALM-AF-AI, a Phase 1/2a trial evaluating AAV9-Follistatin with or without VEGF gene therapy for age-related muscle decline.
Read more
Oliver Zolman MD joins Unlimited Bio XPRIZE Healthspan Team
Unlimited Bio and longevity physician Dr. Oliver Zolman partner to build a one-year, integrated rejuvenation protocol with measurable biomarkers—combining evidence-based lifestyle best practices with investigational therapeutics—to compete in XPRIZE
Read more
Dr. Anna Vakhrusheva joins Dr. Eric Verdin at the Longevity Biomarker Panel
Unlimited Bio participated in the Longevity Biomarkers Summit in Prospera, featuring Eric Verdin (Buck Institute) and discussions on biomarkers, pragmatic risk approaches, and responsible paths to faster healthspan innovation.
Read more
Сlarifications and Сontext for the MIT Technology Review article about Unlimited Bio
Clarifications on MIT Technology Review’s Unlimited Bio article: protocol details, small-n logic, and our safety/ethics stance on VEGF + Follistatin.
Read more
Unlimited Bio Represented at Global Longevity Summit Revive ME in Abu Dhabi
Unlimited Bio CEO Ivan Morgunov joined Revive ME 2025 in Abu Dhabi, presenting a fast-tracked combo-therapy approach to longevity and exploring partnerships across the longevity and healthtech ecosystem.
Read more
Unlimited Bio at the Free Cities Summit in Prague: Longevity as a Human Right
COO Vladimir Leshko represented Unlimited Bio at the Free Cities Conference 2025 in Prague (Oct 31–Nov 2), presenting “Próspera: The Path to Longevity as a Human Right” and connecting with the global Free Cities community.
Read more
Unlimited Bio COO Vladimir Leshko on the Emerging BioTech, MedTech & Web3 Ecosystem in Próspera
Unlimited Bio CEO Vladimir Leshko highlights Próspera’s rise as a global BioTech, MedTech & Web3 hub, Right-to-Try innovation, and investor momentum.
Read more
Longevity.Technology Spotlights Unlimited Bio’s Bold Gene Therapy Strategy
Longevity.Technology profiled Unlimited Bio, highlighting its VEGF therapy in Próspera, upcoming follistatin and combination trials, and a bold goal of 100 studies in 10 years, positioning the company as a fast-moving biotech innovator.
Read more
Unlimited Bio CTO Anna Vakhrusheva Shares Highlights from ARDD 2025 in Copenhagen
<strong>At ARDD 2025 in Copenhagen, Unlimited Bio CTO Anna Vakhrusheva highlighted A. Seluanov’s LINE1 retrotransposon research and bold hTERT biohacker experiments, underscoring ARDD’s role as a premier stage for longevity innovation.</strong>
Read more
Unlimited Bio Founders Join Dr. Matt Kaeberlein on Optispan Podcast
Dr. Matt Kaeberlein spoke with Unlimited Bio founders about the role of offshore clinics in accelerating gene therapies for aging. Unlimited Bio’s roadmap targets 100 clinical trials in 10 years using a combination therapy approach.
Read more
Unlimited Bio CTO Anna Vakhrusheva at RAADfest
At RAADfest 2025, Unlimited Bio CTO Anna Vakhrusheva emphasized that combination gene therapy offers the strongest path to extending healthy lifespan beyond 100 years.
Read more
Unlimited Bio COO Vladimir Leshko Presents Combination Gene Therapy at Genii Longevity Conference
At Genii Longevity Conference 2025 in Geneva, Unlimited Bio COO Vladimir Leshko presented the company’s Combination Gene Therapy strategy, stressing multi-target innovation, global expansion, and the need for new regulatory approaches.
Read more
Unlimited Bio at the U.S. Transhumanist Party Enlightenment Salon
COO Vladimir Leshko presented the Unlimited Bio plans to do human gene therapy combination trials vs aging
Read more
Unlimited Bio placed in the top 100 XPRIZE Healthspan teams
Unlimited Bio is thrilled to be among the Top 100 teams in the XPRIZE Healthspan contest, standing shoulder-to-shoulder with leading universities and public biotech companies.
Read more
Unlimited Bio Showcases Synergistic Gene Therapy Approach at Vitalist Bay
Unlimited Bio presents its multi-gene therapy strategy at Vitalist Bay, showing how combining VEGF, Follistatin, Klotho, and BDNF can enhance longevity outcomes.
Read more
Unlimited Bio COO Vladimir Leshko Explores the Intersection of Space and Longevity at “Health from Space” Conference
Unlimited Bio COO Vladimir Leshko discussed gene therapy for space health, regulatory sandboxes like Próspera, and the shared ambition of space and longevity innovation.
Read more
Pioneering Gene Therapy Cocktail Enters Mouse Trials at Unlimited Bio
A first-of-its-kind combinatorial gene therapy cocktail consisting of VEGF, Follistatin, Klotho, and BDNF is poised for mouse trials, marking an unprecedented advance in genetic medicine.
Read more
Unlimited Bio is on Meet the Drapers
Anna’s compelling pitch at “Meet the Drapers” reinforced Unlimited Bio’s vision and set the stage for our next big breakthrough.
Read more
Unlimited Bio Founders Featured on Infinita City Podcast with Niklas Anzinger
Niklas Anzinger, and the Unlimited Bio team discussed biotech cities, infinite-horizon investing, and flexible governance
Read more
Unlimited Bio Conducts VEGF Plasmid Gene Therapy Administration in Healthy Volunteers
On Feb 14, 2025, Unlimited Bio’s Tristan Roberts and Vladimir Leshko became the first healthy humans to receive VEGF plasmid gene therapy for vascular and muscle rejuvenation.
Read more
BioViva Partnership
Unlimited Bio to license AAV Gene therapies from BioViva
Read more
Unlimited Bio at Zelar City Summit: Exploring the Future of Longevity Science
Unlimited Bio COO Vladimir Leshko joined Zelar City Summit 2025 in Berlin to discuss organ replacement, gene therapy cocktails, and cryonics as pillars of human longevity.
Read more
Unlimited Bio Partners with Artgen Biotech to Advance VEGF Plasmid Gene Therapy
Unlimited Bio and Artgen Biotech join forces to explore VEGF plasmid gene therapy for cosmetic and regenerative uses, enhancing skin, muscle, and hair health.
Read more